{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:03:33Z","timestamp":1791896613210,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["C06 RR 12087"],"award-info":[{"award-number":["C06 RR 12087"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["C06 RR016228"],"award-info":[{"award-number":["C06 RR016228"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["P51 OD011133"],"award-info":[{"award-number":["P51 OD011133"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["P51 RR13986"],"award-info":[{"award-number":["P51 RR13986"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1053\/j.gastro.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T23:16:54Z","timestamp":1360711014000},"page":"1508-1517.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":348,"title":["GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees"],"prefix":"10.1053","volume":"144","author":[{"given":"Robert E.","family":"Lanford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Giavedoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida L.","family":"Hodara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Fosdick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grushenka","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall L.","family":"Halcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Tumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2013.02.003_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrgastro.2011.33","article-title":"Hepatitis B therapy","volume":"8","author":"Kwon","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2013.02.003_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1478-3231.2010.02384.x","article-title":"Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?","volume":"31","author":"Sonneveld","year":"2011","journal-title":"Liver Int"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2013.02.003_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3851\/IMP1619","article-title":"Molecular genetics of HBV infection","volume":"15","author":"Locarnini","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1053\/j.gastro.2013.02.003_bib4","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2009.01.016","article-title":"High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study","volume":"50","author":"Moucari","year":"2009","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2013.02.003_bib5","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2009.03.006","article-title":"Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a","volume":"136","author":"Marcellin","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.02.003_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jhep.2010.07.046","article-title":"Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir","volume":"54","author":"Reijnders","year":"2011","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2013.02.003_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-immunol-031210-101340","article-title":"Nucleic acid recognition by the innate immune system","volume":"29","author":"Barbalat","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.gastro.2013.02.003_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-8749(02)00517-8","article-title":"Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod","volume":"218","author":"Gibson","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1053\/j.gastro.2013.02.003_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1053\/j.gastro.2013.02.003_bib10","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood-2011-04-348839","article-title":"TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway","volume":"118","author":"Oh","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2013.02.003_bib11","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1053\/j.gastro.2013.02.003_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists","volume":"13","author":"Kanzler","year":"2007","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2013.02.003_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2036.2011.04745.x","article-title":"Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV","volume":"34","author":"Bergmann","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2013.02.003_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2007.02.025","article-title":"Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies","volume":"47","author":"Pockros","year":"2007","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2013.02.003_bib15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/clpt.2011.60","article-title":"The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691)","volume":"89","author":"Fidock","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.gastro.2013.02.003_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.patbio.2009.11.001","article-title":"Pathogenesis of hepatitis B virus infection","volume":"58","author":"Chisari","year":"2010","journal-title":"Pathol Biol (Paris)"},{"key":"10.1053\/j.gastro.2013.02.003_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.gastro.2013.02.003_bib18","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1128\/JVI.00700-09","article-title":"Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection","volume":"83","author":"Mason","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2013.02.003_bib19","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1073\/pnas.1101939108","article-title":"Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA","volume":"108","author":"Lanford","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.02.003_bib20","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.02.003_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.21167","article-title":"Genomic response to interferon-\u03b1 in chimpanzees: implications of rapid downregulation for hepatitis C kinetics","volume":"43","author":"Lanford","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2013.02.003_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-8278(00)80418-3","article-title":"Hepatitis B infection: pathogenesis and management","volume":"32","author":"Lok","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2013.02.003_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3851\/IMP1499","article-title":"Molecular genesis of drug-resistant and vaccine-escape HBV mutants","volume":"15","author":"Locarnini","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1053\/j.gastro.2013.02.003_bib24","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2165\/10482940-000000000-00000","article-title":"Tenofovir disoproxil fumarate in chronic hepatitis B","volume":"69","author":"Perry","year":"2009","journal-title":"Drugs"},{"key":"10.1053\/j.gastro.2013.02.003_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.24078","article-title":"No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus","volume":"53","author":"Snow-Lampart","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2013.02.003_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","article-title":"Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B","volume":"140","author":"Heathcote","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2013.02.003_bib27","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/JVI.74.9.4165-4173.2000","article-title":"Intrahepatic induction of alpha\/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice","volume":"74","author":"Wieland","year":"2000","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2013.02.003_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.gastro.2013.02.003_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2013.02.003_bib30","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1073\/pnas.0308478100","article-title":"Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.02.003_bib31","doi-asserted-by":"crossref","first-page":"11652","DOI":"10.1073\/pnas.1635109100","article-title":"Hepatocyte turnover during resolution of a transient hepadnaviral infection","volume":"100","author":"Summers","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.02.003_bib32","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/eji.200940098","article-title":"Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo","volume":"40","author":"Persson","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.gastro.2013.02.003_bib33","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1016\/S0168-8278(11)61116-1","article-title":"Anti-viral efficacy and induction of an antibody response against surface antigen with the TLR7 agonist GS-9620 in the woodchuck model of chronic HBV infection","volume":"54","author":"Menne","year":"2011","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2013.02.003_fr1","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1128\/JVI.00700-09","article-title":"Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection","volume":"83","author":"Mason","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2013.02.003_fr2","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1073\/pnas.1101939108","article-title":"Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA","volume":"108","author":"Lanford","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2013.02.003_fr3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1006\/viro.1993.1299","article-title":"Carboxy-terminal truncations of the HBV core protein affect capsid formation and size of the encapsidated HBV RNA","volume":"194","author":"Beames","year":"1993","journal-title":"Virology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508513001698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508513001698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:41:51Z","timestamp":1762162911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508513001698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0016508513001698"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2013.02.003","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2013.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}